Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Extending our understanding of exenatide: a rare case of angio-oedema
physicians found that Real-World Evidence was ranked as the most influential data source informing treatment decisions, even ahead of traditional clinical trial data
This expert group agreed with the recommended treatment targets for patients with T2D and established or high-risk CVD from the ADA and ESC guidelines
No clinical, therapeutic, diagnostic, or human-use claim is made or implied for this product, and no comparison to any commercial product is made or implied
US$ 27.88
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 29.23
US$ 28.06
